USD10
FULC Shares
About Fulcrum TherapeuticsFulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
USD10
FULC Shares
About Fulcrum TherapeuticsFulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$243.21M
OPEN PRICE
$3.47
LOW (1Y)
$2.83
HIGH (1Y)
$15.74
LOW (24H)
$3.46
HIGH (24H)
$3.79
VOLUME (24H)
$2.31M
15.4%
Price history
Time | Price | Change |
|---|---|---|
Today | $3.47 | |
1 Day | $3.51 | |
1 Week | $3.39 | |
1 Month | $3.50 | |
1 Year | $7.10 |
Past performance is not a reliable indicator of future results.
Discover more
Explore other stocks
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.